How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Traditional Medicine Extract Market
- By Source Plant Type: Ginseng Extract, Ginkgo Biloba Extract, Turmeric Extract, Echinacea Extract, Glycyrrhiza (Licorice) Extract
- By Form: Powder, Liquid Extract, Capsules, Tinctures, Ointments
- By Application: Dietary Supplements, Pharmaceuticals, Cosmetics, Functional Foods, Traditional Remedies
- By Extraction Method: Solvent Extraction, Supercritical CO2 Extraction, Steam Distillation, Cold Press Extraction, Ultrasound-Assisted Extraction
- By End-User: Hospitals and Clinics, Herbal Medicine Manufacturers, Nutraceutical Companies, Personal Care Product Manufacturers, Research Institutions
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Ginseng Extract leads By Source Plant Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Traditional Medicine Extract Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Eu Yan Sang International Ltd
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Tong Ren Tang Technologies Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Tasly Pharmaceutical Group Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →China Traditional Chinese Medicine Holdings Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Hunan Zhongyan Pharmaceutical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Jiangyin Tianjiang Pharmaceutical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Harbin Pharmaceutical Group Co. Ltd. (Hayao)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Luye Pharma Group Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Yunnan Baiyao Group Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Shandong Buchang Pharmaceuticals Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Inner Mongolia Baiyunshan Pharmaceutical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →KPC Pharmaceuticals
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Kampo Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Kangmei Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Ginseng Extract50.3
- Ginkgo Biloba Extract12.7
- Turmeric Extract14.4
- Echinacea Extract7.5
- Glycyrrhiza (Licorice) Extract15.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Eu Yan Sang International Ltd13.4
- Tong Ren Tang Technologies Co. Ltd.20.2
- Tasly Pharmaceutical Group Co. Ltd.9.7
- China Traditional Chinese Medicine Holdings Co. Ltd.6.7
- Hunan Zhongyan Pharmaceutical Co. Ltd.11.2
- Jiangyin Tianjiang Pharmaceutical Co. Ltd.10.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.3
- Europe24.2
- Asia Pacific22.5
- Latin America12.9
- Middle East and Africa10.1
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Eu Yan Sang International Ltd | 80 | 96 | 82 | 90 | 79 | 97 | 87 |
| Tong Ren Tang Technologies Co. Ltd. | 85 | 80 | 70 | 88 | 87 | 79 | 82 |
| Tasly Pharmaceutical Group Co. Ltd. | 84 | 73 | 63 | 78 | 71 | 87 | 76 |
| China Traditional Chinese Medicine Holdings Co. Ltd. | 70 | 80 | 81 | 76 | 63 | 78 | 75 |
| Hunan Zhongyan Pharmaceutical Co. Ltd. | 63 | 73 | 71 | 55 | 51 | 74 | 65 |
| Jiangyin Tianjiang Pharmaceutical Co. Ltd. | 57 | 68 | 61 | 69 | 53 | 70 | 63 |
| Harbin Pharmaceutical Group Co. Ltd. (Hayao) | 60 | 59 | 55 | 48 | 61 | 62 | 58 |
| Luye Pharma Group Ltd. | 57 | 48 | 41 | 56 | 58 | 48 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Eu Yan Sang International Ltd
- Tong Ren Tang Technologies Co. Ltd.
- Tasly Pharmaceutical Group Co. Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Eu Yan Sang International Ltd | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Tong Ren Tang Technologies Co. Ltd. | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Tasly Pharmaceutical Group Co. Ltd. | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| China Traditional Chinese Medicine Holdings Co. Ltd. | ◐ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Hunan Zhongyan Pharmaceutical Co. Ltd. | ◐ | ✓ | ◐ | ◐ | − | ◐ |
| Jiangyin Tianjiang Pharmaceutical Co. Ltd. | ◐ | − | ✓ | ✓ | ◐ | ◐ |
| Harbin Pharmaceutical Group Co. Ltd. (Hayao) | − | − | ◐ | − | − | ◐ |
| Luye Pharma Group Ltd. | − | ◐ | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender3
Focused players with pockets of strength.
Niche1
Specialists in a single segment or region.
Go-to-market strategy
Land Source Plant Type in North America, then scale across Traditional Medicine Extract Market — a $550M beachhead inside a $8.87B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Ginseng Extract
Best fit — highest urgency & budget in Source Plant Type.
Ginkgo Biloba Extract
Strong fit — clear ROI and a fast path to value.
Turmeric Extract
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source Plant Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Source Plant Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Traditional Medicine Extract Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Traditional Medicine Extract Market is a high-growth opportunity — $9.98B by 2033, compounding at 10.3%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.3% CAGR
Demand compounds through 2033, outpacing GDP across Source Plant Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source Plant Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Traditional Medicine Extract Market — a $5.83B market by 2033. Plan: grow share from 11.9% to 18.4%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.9% | 18.4% | On track |
| Revenue | $694M | $1.07B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.8% | 42.6% | On track |
| Customer retention | 90.6% | 95.0% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Source Plant Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source Plant Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $128M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Source Plant Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Traditional Medicine Extract Market conversation — a $2.93B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source Plant Type
Goal Grow share in Source Plant Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Traditional Medicine Extract Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Traditional Medicine Extract Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Traditional Mirror Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportTraditional Music Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportTraditional Pump Coffee Machine Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportTraditional Signage Market
Market size, share, segmentation and regional forecast.
$683M market · 2025 base year
View reportTraditional Sofa Ded Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportTraditional Sofa Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportTraditional Storage Furniture Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportTraditional Tables Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportTraditional Toys Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportTraditional Upholstered Benches For Residential Aera Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportTraditional Upholstered Benches Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportTraditional Wall-Mounted Shower Set Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy